cover image

23andMe

American personal genomics company / From Wikipedia, the free encyclopedia

Dear Wikiwand AI, let's keep it short by simply answering these key questions:

Can you list the top facts and stats about 23andMe?

Summarize this article for a 10 years old

SHOW ALL QUESTIONS

23andMe Holding Co. is a publicly held personal genomics and biotechnology company based in South San Francisco, California.[1][2] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping,[3] to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.[4]

Quick facts: Type, Traded as, Industry, Founded, Founders...
23andMe Holding Co.
TypePublic
Nasdaq: ME
Industry
FoundedApril 2006; 17 years ago (2006-04)
Founders
Headquarters,
United States
Key people
Anne Wojcicki (CEO)
Esther Dyson (board member)
ProductsDirect-to-consumer personal genome testing
Mobile application
ServicesGenetic testing, genealogical DNA testing, medical research
RevenueIncrease US$299 million (2023)
Decrease US$−324 million (2023)
Decrease US$−312 million (2023)
Total assetsDecrease US$943 million (2023)
Total equityDecrease US$714 million (2023)
Number of employees
816 (2023)
Website23andme.com
Footnotes / references
Financials as of March 31, 2023[1]
Close

The company had a previously fraught relationship with the United States Food and Drug Administration (FDA) due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval.[5][6] 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014,[7][8][9] and in the UK since December 2014.[10]

In 2007, 23andMe became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use.[11] Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.[12][13][14]